title: Therapeutic potentials of androgens, estrogen and SERMs in glucocorticoid-induced osteoporosis.
authors.affiliation: Eli Lilly & Co., Florence, Italy. agnusdei_donato@lilly.com
authors.forename: D
authors.initials: D
authors.lastname: Agnusdei
authors.forename: G C
authors.initials: GC
authors.lastname: Isaia
authors.forename: N
authors.initials: N
authors.lastname: Iori
mesh_terms: D000728:Androgens / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*
chemical_list: D000728:Androgens; D004967:Estrogens; D005938:Glucocorticoids; D020845:Selective Estrogen Receptor Modulators